Previous 10 | Next 10 |
HAIFA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Pluri Inc . (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote global wellbeing and sustainability, today announced leadership from its business verticals wil...
HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) ("Pluri" or the “Company"), a leading biotechnology company that transforms cells into solutions, today announced that a reverse share split of the Company’s issued and outstanding common shares...
2024-03-26 12:16:24 ET More on PJT Partners PJT Partners: Early In The Wave PJT Partners Inc. (PJT) Q4 2023 Earnings Call Transcript PJT Partners Q4 2023 Earnings Preview Goldman turns bearish on Perella Weinberg Partners, neutral on PJT Partners Seek...
International Coffee Organization (ICO) Market Report published o n March 7, 2024 highlights alarming price instability challenging the coffee industry According to the report, adverse weather conditions, first noted in 2022 an...
HAIFA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote global wellbeing and sustainability, today announced its participation in the following upcoming con...
HAIFA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions, today announced that its CDMO division (PluriCDMO™) has signed a manufacturing agreement with Remedy Cell...
HAIFA, Israel, March 11, 2024 (GLOBE NEWSWIRE) -- In a strategic move that underscores its innovative edge in the agtech sector, Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company") today announced an important expansion to its intellectual property portfolio with a new patent approval...
HAIFA, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote global wellbeing and sustainability, today announced the appointment of atto...
Growing pipeline of industry-specific new potential products, services, collaborations and partnerships through PluriAg t ech , PluriCDMO , PluriHealth , and PluriFood Recent achieve ments include: new cell-based coffee business; ...
2024-02-21 16:50:09 ET Summary PJT Partners is a leader in restructuring, driving their overall growth with robust mandates. Other companies like Moelis are also posting good quarters from restructuring, but PJT got started earlier. Park Hill, the placement business, is strugg...
News, Short Squeeze, Breakout and More Instantly...
PJT Partners Inc. Class A Company Name:
PJT Stock Symbol:
NYSE Market:
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Placental Mucosal Associated Invariant T (MAIT) cells are unique unconventional immune T cells which are particularly suitable for the treatment of solid tumors, a significant unmet medical need MAIT cells offer unique advantages compared to conventional T cells MAIT cells hold immense po...
First Quarter Overview Record First Quarter Revenues of $329 million, an increase of 65% from a year ago GAAP Pretax Income of $54 million and Adjusted Pretax Income of $55 million, an increase of 85% and 81%, respectively, from a year ago GAAP Diluted EPS of $1.22 and Adjusted EP...